Literature DB >> 17616378

Swellable elementary osmotic pump (SEOP): an effective device for delivery of poorly water-soluble drugs.

Javad Shokri1, Parinaz Ahmadi, Parisa Rashidi, Mahbobeh Shahsavari, Ali Rajabi-Siahboomi, Ali Nokhodchi.   

Abstract

A new type of elementary osmotic pump (EOP) tablet for efficient delivery of poorly water-soluble/practically insoluble drugs has been designed. Drug release from the system, called swellable elementary osmotic pump (SEOP), is through a delivery orifice in the form of a very fine dispersion ready for dissolution and absorption. SEOP tablets were prepared by compressing the mixture of micronized drug and excipients into convex tablets. Factors affecting the release of drug from the SEOP tablets containing a poorly water-soluble drug, indomethacin, have been explored. The release behaviour of indomethacin from different formulations of this dosage form was studied at pH 6.8 for a period of 24h. The formulations were compared based on four comparative parameters, namely, D(24h) (total release after 24h), t(L) (lag time), RSQ(zero) (R square of zero order equation) and D%(zero) (percentage deviation from zero order kinetics). The drug release profile from osmotic devices showed that the type of polymer in the core formulation can markedly affect the drug release. The results showed that concentration of wetting agent in the core formulation was a very important parameter in D(24h) and release pattern of indomethacin from SEOP system. Increasing the amount of wetting agent to an optimum level (60mg) significantly increased D(24h) and improved zero order release pattern of indomethacin. Increasing concentration of caster oil (hydrophobic) in the semipermeable membrane of the device or hydrophilic plasticizer (glycerin) in coating formulation markedly increased t(L) and decreased D(24h). The results also demonstrated that aperture size is a critical parameter and should be optimized for each SEOP system. Optimum aperture diameter for the formulations studied here was determined to be 650microm for zero order release pattern. t(L) and D%(zero) were dramatically decreased whereas D(24h) and RSQ(zero) increased with increasing the aperture size to optimum level. This study also revealed that optimization of semipermeable membrane thickness is very important for approaching zero order kinetics.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17616378     DOI: 10.1016/j.ejpb.2007.06.006

Source DB:  PubMed          Journal:  Eur J Pharm Biopharm        ISSN: 0939-6411            Impact factor:   5.571


  9 in total

1.  Development of push-pull osmotic tablets using chitosan-poly(acrylic acid) interpolymer complex as an osmopolymer.

Authors:  Wichan Ketjinda; Nuttanan Sinchaipanid; Pichet Limsuwan; Hans Leuenberger; Ampol Mitrevej
Journal:  AAPS PharmSciTech       Date:  2010-12-23       Impact factor: 3.246

2.  Controlled porosity solubility modulated osmotic pump tablets of gliclazide.

Authors:  Arti Banerjee; P R P Verma; Subhash Gore
Journal:  AAPS PharmSciTech       Date:  2014-11-07       Impact factor: 3.246

3.  Development and in vitro/in vivo evaluation of etodolac controlled porosity osmotic pump tablets.

Authors:  Ahmed Abd-Elbary; Mina Ibrahim Tadros; Ahmed Adel Alaa-Eldin
Journal:  AAPS PharmSciTech       Date:  2011-04-09       Impact factor: 3.246

4.  The role of sodium lauryl sulfate on formulation of directly compressed tablets containing simvastatin and aspirin: Effect on drugs dissolution and gastric mucosa.

Authors:  Doaa H Alshora; Mohamed A Ibrahim; Gamal Zayed; Mohammed A Al Rwashed; Heba A Abou-Taleb; Marwa F Ali
Journal:  Saudi Pharm J       Date:  2022-02-14       Impact factor: 4.562

5.  Investigation of release pattern of a drug with low solubility through asymmetric membrane capsules.

Authors:  P K Sahoo; Harleen Makar
Journal:  Indian J Pharm Sci       Date:  2013-03       Impact factor: 0.975

6.  Feasibility of optimizing trimetazidine dihydrochloride release from controlled porosity osmotic pump tablets of directly compressed cores.

Authors:  Basant A Habib; Randa T Abd El Rehim; Samia A Nour
Journal:  J Adv Res       Date:  2013-06-11       Impact factor: 10.479

7.  Development and optimization of buspirone oral osmotic pump tablet.

Authors:  K Derakhshandeh; M Ghasemnejad Berenji
Journal:  Res Pharm Sci       Date:  2014 Jul-Aug

8.  Formulation and evaluation of controlled porosity osmotic pump for oral delivery of ketorolac.

Authors:  Fatima Sanjeri Dasankoppa; Mahesh Ningangowdar; Hasanpasha Sholapur
Journal:  J Basic Clin Pharm       Date:  2012-12

Review 9.  Strategies in Forward Osmosis Membrane Substrate Fabrication and Modification: A Review.

Authors:  Nur Diyana Suzaimi; Pei Sean Goh; Ahmad Fauzi Ismail; Stanley Chinedu Mamah; Nik Ahmad Nizam Nik Malek; Jun Wei Lim; Kar Chun Wong; Nidal Hilal
Journal:  Membranes (Basel)       Date:  2020-11-07
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.